Aprotinin in pediatric cardiac operations: A benefit in complex malformations and with high-dose regimen only

Annals of Thoracic Surgery

Volumn 66, Issue 1, 1998, Pages 153-158

  Carrel, Thierry P ^a,b   Schwanda, Mike ^a   Vogt, Paul R ^a   Turina, Marko I ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD CLOTTING; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PEDIATRIC SURGERY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT INDICATION; TREATMENT OUTCOME;

ANESTHESIA, GENERAL; APROTININ; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEMOSTATICS; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; PLATELET COUNT; SAFETY; TETRALOGY OF FALLOT; TRANSPOSITION OF GREAT VESSELS;

EID: 0032126606     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00396-8     Document Type: Article

References (23)

1. 1. Kern FH, Morana MJ, Sears JJ, Hickey PR. Coagulation defects in neonates undergoing cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
2. 2. Guay J, Rivard GE. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996;62: 1955-60.
3. 3. Hartstein G, Janssens M. Treatment of excessive mediastinal bleeding after cardiopulmonary bypass. Ann Thorac Surg 1996;62:1951-4.
4. 4. Janssens M, Hartstein G, David JL. Reduction in requirements for allogeneic blood products: pharmacologic methods. Ann Thorac Surg 1996;62:1944-50.
5. 5. Terrell MR, Walenga JM, Koza MJ, Pifarré R. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass. Ann Thorac Surg 1996;62:506-12.
6. 6. Emerson TE. Pharmacology of aprotinin and efficacy during cardiopulmonary bypass. Cardiovasc Drug Rev 1989;7: 127-40.
7. 7. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995;110:1658-62.
8. 8. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993;55:971-6.
9. 9. Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55:1033-41.
10. 10. Boldt J, Knothe C, Zickman B, Wege N, Dapper F, Hempelmann G. Aprotinin in pediatric cardiac operations: platelet function, blood loss and use of homologous blood. Ann Thorac Surg 1993;55:1460-6.
11. 11. Boldt J, Knothe C, Zickman B, Wege N, Dapper F, Hempelmann G. Comparison of two aprotinin dosage regimen in pediatric patients having cardiac operations: influence on platelet function and blood loss. J. Thorac Cardiovasc Surg 1993;105:705-11.
12. 12. Herynkopf F, Lucchese F, Pereira E, Kalil R, Prates P, Nesralla A. Aprotinin in children undergoing correction of congenital defects; a double blind pilot study. J Thorac Cardiovasc Surg 1994;108:517-21.
13. 13. Elliott MJ, Allen A. Aprotinin in pediatric cardiac surgery. Perfusion 1990;5(Suppl):73-6.
14. 14. Urban AE, Popov-Cenic S, Noa G, Kulzer R. Aprotinin in open heart surgery of infants and children using the heart-lung machine. Clin Ther 1984;6:425-33.
15. 15. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open-heart surgery in children. Blood 1991;77:930-6.
16. 16. Seear MD, Wesworth LD, Rogers PC, Sheps S, Ashmore PG. The effect of desmopressin acetate on postoperative blood loss after cardiac operation in children. J Thorac Cardiovasc Surg 1989;98:217-9.
17. 17. Whitten CW, Allison PM, Latson TW, Bossard RF, Rosenberg JA, Ring WS. Management of the thrombocytopenic cardiac surgical patient. A role for aprotinin? Anesth Analg 1994;79:796-800.
18. 18. Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11-8.
19. 19. Tabuchi N, de Haan J, Boonstra PW, Huet RCG, van Oeveren W. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. Eur J Cardiothorac Surg 1994;8:87-90.
20. 20. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
21. 21. Mössinger H, Dietrich W, Spannagel M, Henze R, Barankay A, Richter JA. High-dose aprotinin reduces not only fibrinolytic, but also clotting activation in pediatric cardiac surgery. 15th Annual Meeting of Cardiovascular Anesthesiology, 1993:249.
22. 22. Dietrich W, Späth P, Ebell A, Richter JA. Incidence of anaphylactic reactions to aprotinin - analysis of 248 reexposures to aprotinin [Abstract]. Anesthesiology 1995;83:A104.
23. 23. Davies MJ, Allen A, Kort H, et al. Prospective, randomized double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997;63:497-503.